Jonathan Mason PhD

Dr. Jonathan Mason is a Senior Research Fellow at Heptares Therapeutics in the UK leading Computer-Assisted Drug Design (CADD) approaches for GPCR structure-based drug design, scientifically responsible for the computational chemistry team. A ‘high end’ GPCR design approach combining structure, water energetics, lipophilic hotspots and biophysical data is being developed.